Poseida Therapeutics
Poseida Therapeutics is a biotechnology company specializing in the development of gene therapies for cancers and rare genetic diseases, utilizing advanced systems like the piggyBac DNA Delivery and Cas-CLOVER Gene Editing technologies.
Company Overview
Poseida Therapeutics develops new solutions for life-threatening cancers and genetic diseases using advanced genetic engineering technologies. The company utilizes the non-viral piggyBac DNA Delivery System and the Cas-CLOVER Site-Specific Gene Editing System to create innovative treatments. Poseida's focus on cell type-specific therapies aims to advance fully allogeneic CAR-T therapies and develop cures for rare genetic diseases.
Innovative Genetic Engineering Technologies
Poseida Therapeutics leverages the non-viral piggyBac DNA Delivery System and the Cas-CLOVER Site-Specific Gene Editing System in its development processes. The piggyBac system enables precise DNA integration without the use of viral vectors, while Cas-CLOVER allows for targeted gene editing with high specificity. These technologies are central to Poseida's approach in developing cutting-edge treatments for cancer and genetic disorders.
Pipeline and Research Focus
Poseida Therapeutics' pipeline includes allogeneic CAR-T therapies for oncology and gene therapies for rare diseases. The company is actively developing cell type-specific therapies designed to potentially advance fully allogeneic CAR-T treatments. Poseida has presented significant progress in their genetic medicine programs, notably at the American Society for Gene and Cell Therapy 27th Annual Meeting.
Collaborations and Partnerships
Poseida Therapeutics is engaged in strategic collaborations to enhance its research and development capabilities. The company has a research collaboration and license agreement with Astellas to develop novel allogeneic cell therapies in oncology. In addition, Poseida has partnerships with Roche focusing on therapies for hematologic malignancies. These collaborations are integral to advancing Poseida's innovative therapies.